DIRS.INFO The most relevant business & tech news

☆ Boar's Head recall expands to include 7 million pounds of deli meat over listeria concerns
▼ + stars: | 2024-07-31 | by ( Marlene Lenthang | Aria Bendix | ) www.cnbc.com time to read: +4 min

A recall of Boar's Head products has expanded to include a whopping 7 million additional pounds of deli and poultry items in a deadly multistate outbreak of listeria infections. As of Tuesday, 34 people have gotten sick across 13 states in the outbreak — including 33 hospitalizations and two deaths. Last week, the deli meat company had recalled more than 207,000 pounds of deli meat, including liverwurst and ham products, because they may contain the bacteria Listeria monocytogenes. Boar's Head has now expanded that recall, the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) announced in a press release Tuesday. Boar's Head said in a statement on its website that it had initiated the recall after a liverwurst sample collected by the Maryland Department of Health had tested positive for listeria.

Persons: Boar's Organizations: U.S . Department of Agriculture's, Inspection, Brand, Maryland Department of Health, The Maryland Department of Health, Baltimore City Health Department, Centers for Disease Control, Mayo Clinic, CDC Locations: Montebello , California, Illinois, New Jersey, Cayman Islands, Dominican Republic, Mexico, Panama, Virginia, U.S

☆ GEHC gives reasons to look beyond temporary China woes and shares reverse higher
▼ + stars: | 2024-07-31 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

GE Healthcare on Wednesday morning reported a mixed second quarter and shares initially moved sharply lower. Organic revenue growth was 1%. We saw a continued acceleration of Vizamyl doses delivered in the U.S. in the second quarter. This is still a small contributor to sales growth but gives us optimism about its sales potential over the next few years." As a result, we're lowering our total company full-year organic revenue growth guidance."

Persons: Philips, It's, Eli Lilly, GEHC, —, Jay Saccaro, We're, Arduini, Peter Arduini, Jim Cramer's, Jim Cramer, Jim, Pavlo Gonchar Organizations: GE Healthcare, Management, Revenue, LSEG, General Electric, Philips, Siemens, Club, GE Healthcare YTD, GE Healthcare's, Care Solutions, Pharmaceutical Diagnostics, U.S, CNBC, Lightrocket, Getty Locations: China, Eisai, U.S

☆ Shirley Chung of ‘Top Chef’ has stage 4 tongue cancer
▼ + stars: | 2024-07-31 | by ( Lisa Respers France | ) edition.cnn.com time to read: +2 min

CNN —“Top Chef” alum Shirley Chung has gone public with her cancer diagnosis. “A few days later, I was diagnosed, stage 4 tongue cancer, as cancer cells also spread into my lymph nodes,” Chung, 47, wrote. While it meant relocating for treatment, Chung said she decided to try it. “Cheer me on, Shirley Chung 2.0 will be reborn in 2025!”According to the American Cancer Society, more than 58,000 new cases of oral cavity and oropharyngeal cancers are diagnosed in the United States each year. Acclaimed chef Grant Achatz spoke with NPR in a 2011 interview about his own experience with stage 4 tongue cancer and undergoing treatment at the University of Chicago.

Persons: ”, Shirley Chung, Chung, ” Chung, “, I’ve, she’s, Grant Achatz Organizations: CNN, University of Chicago, American Cancer Society, NPR Locations: United States

☆ Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
▼ + stars: | 2024-07-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

The newly FDA approved Alzheimer's treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA., on Tuesday, November 7, 2023. The breakthrough Alzheimer's drug Leqembi slowed disease progression in patients over three years, demonstrating the need for them to stay on the treatment long term, according to new data released Tuesday by Japanese drugmaker Eisai. The study results on Leqembi, which Eisai shares with Biogen , also found that a patient's Alzheimer's disease worsens after they stop treatment. The results are a first glimpse at what Alzheimer's patients' future could look like on therapies such as Leqembi, which is currently taken twice a month through an infusion. By 2050, the number of Alzheimer's patients is projected to rise to almost 13 million in the U.S.

Persons: Lynn Kramer, Leqembi, Eisai, Kramer Organizations: FDA, Abington Neurological Associates, Biogen, CNBC, Alzheimer's Association International Conference, Alzheimer's Association Locations: Abington, Abington , PA, U.S, Philadelphia

☆ Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial
▼ + stars: | 2024-07-30 | by ( Meg Tirrell | ) edition.cnn.com time to read: +7 min

“This is the first study that actually looked at a relatively large number of patients for whether there is any neuroprotective effect in Alzheimer’s disease,” Edison said. The trial enrolled predominantly people with mild Alzheimer’s disease, measured by a test known as the Mini-Mental State Examination, a scale that goes up to 30. The GLP-1 drug class also includes Eli Lilly’s Mounjaro and Zepbound, which use the active ingredient tirzepatide, which mimics not just the hormone GLP-1 but another called GIP. But it hasn’t announced any trials of its GLP-1 drugs in Alzheimer’s. GLP-1 drugs can have side effects, though, primarily gastrointestinal problems like nausea and vomiting.

Persons: liraglutide, “, ”, Maria Carrillo, Carrillo, Paul Edison, ” Edison, Edison, Eli Lilly’s Mounjaro, Alzheimer’s Lilly, hasn’t, Lilly, Lars Fruergaard Jorgensen, there’s, Dr, Sanjay Gupta, semaglutide Organizations: CNN, Alzheimer’s Association International Conference, Alzheimer’s Association, Novo Nordisk, Imperial College London, ”, Nordisk, ” Novo Nordisk, CNN Health, University of Oxford, Alzheimer’s Society, Alzheimer’s Locations: United Kingdom, Philadelphia, Alzheimer’s, ” Novo, Danish

☆ Neuralink rival Synchron lets patients control Apple Vision Pro with their thoughts
▼ + stars: | 2024-07-30 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +2 min

Neurotech startup Synchron on Tuesday announced it has connected its brain implant to Apple 's Vision Pro headset. Apple released the Vision Pro earlier this year, and users typically control it with eye movements, voice commands and hand gestures. He said Synchron will likely work to connect its BCI to other headsets, but it's starting with the Vision Pro. Apple has been "very supportive" of the Vision Pro integration, he added. Synchron is a part of an increasingly competitive BCI industry, and the company said Tuesday that it is the first to connect its system to Apple's Vision Pro.

Persons: Synchron, Thomas Oxley, Oxley, Elon Musk's, It's Organizations: BCI, U.S . Food, Drug Administration, Apple, Vision, CNBC, Neuroscience, Blackrock Neurotech Locations: U.S, Australia

☆ Here's everything you need to know about the Fed decision coming Wednesday
▼ + stars: | 2024-07-30 | by ( Jeff Cox | ) www.cnbc.com time to read: +6 min

Market pricing currently indicates an absolute certainty that the Fed will approve its first reduction in more than four years — when it meets Sept. 17-18. They don't want investors to start pricing in a rate cut coming in September and there's literally nothing else that could possibly happen," he said. "Opening the door for that rate cut is probably the most appropriate thing for them at this point," Reynolds added. Expectations for easingGlenmede expects that starting in September, the Fed could cut at each of the three remaining meetings. The Fed will not provide an update on its quarterly summary of economic projections at this meeting.

Persons: Jerome Powell, Chris Kleponis, they've, Michael Reynolds, Reynolds, there's, it'll, Powell, Goldman Sachs, David Mericle, Mericle, Bill English, We've Organizations: Banking, Housing, Urban, Capitol, AFP, Getty, Glenmede, Fed Locations: Washington ,, Yale, Jackson Hole , Wyoming

☆ Weight-loss drugs could stave off dementia, small study finds
▼ + stars: | 2024-07-30 | by ( Hilary Brueck | ) www.businessinsider.com time to read: +6 min

Today, a group of dementia researchers from the UK released some early results that suggest it's possible these trendy injections might also stall the progression of dementia. A daily injection for brain preservationIuliia Burmistrova/Getty ImagesFor the study, researchers spent a year tracking brain changes across 204 Alzheimer's patients with mild to moderate disease. "It sounds like it is worth pursuing a larger trial, but these results cannot demonstrate that liraglutide can protect against dementia." Experts have seen how dementia patients' brains get worse and worse at efficiently using glucose for energy as their disease progresses, but the calculus is always complicated. Bigger studies using more powerful GLP-1 drugs for dementia are already ongoing.

Persons: Stephen Evans, Jason Kirk, Quynh Nguyen, hadn't, Dr, Paul Edison, it's, Edison, Alzheimer's Organizations: Service, Alzheimer's Association International Conference, London School of Hygiene, Medicine, Science Media, Nikon, Imperial College London, Food and Drug Administration, Novo Nordisk Locations: Philadelphia, Novo

☆ Scientists say weight-loss drugs could protect our brains from dementia. Early results suggest they're onto something.
▼ + stars: | 2024-07-30 | by ( Hilary Brueck | ) www.businessinsider.com time to read: +6 min

☆ Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
▼ + stars: | 2024-07-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

George Frey | ReutersAn older, once-daily drug for diabetes and obesity from Novo Nordisk called liraglutide may slow the progression of Alzheimer's disease by protecting patients' brains, according to data from a mid-stage trial released on Tuesday. Novo Nordisk sells liraglutide as a diabetes and obesity drug under the brand names Victoza and Saxenda, respectively. Alzheimer's disease often causes the brain to shrink as the illness progresses because crucial nerve cells break down and stop working properly. By 2050, the number of Alzheimer's patients is projected to rise to almost 13 million in the U.S. The ongoing EVOKE is examining semaglutide, the active ingredient in Wegovy and Ozempic, in nearly 2,000 Alzheimer's patients.

Persons: George Frey, Eli Lilly, liraglutide, Brian B, Bettencourt, Heather Snyder, Leqembi, Snyder, Dr, Paul Edison, Edison, Bobby Pugh, Bessie Pugh, Karen Pulfer Focht Organizations: Novo Nordisk Pharmaceutical, Reuters, Novo Nordisk, Imperial College London, Alzheimer's Association International Conference, Toronto Star, Getty, Alzheimer's Association, U.S, CNBC, Alzheimer's, Novo Nordisk's, Ave Locations: Provo , Utah, Danish, Philadelphia, Biogen, Novo, Bartlett , Tennessee, U.S

☆ Inside the Supreme Court’s compromise on Idaho’s abortion ban
▼ + stars: | 2024-07-29 | by ( Joan Biskupic | ) edition.cnn.com time to read: +13 min

Instead, a series of negotiations led to an eventual compromise decision limiting the Idaho law and temporarily forestalling further limits on abortion access from the high court. This exclusive series on the Supreme Court is based on CNN sources inside and outside the court with knowledge of the deliberations. The Idaho law had exemptions only to prevent death of the pregnant woman and in instances of rape or incest. It issued formal guidance saying the Emergency Medical Treatment and Labor Act (EMTALA), which requires stabilizing treatment regardless of a patient’s ability to pay, would preempt any state abortion ban in situations when an emergency termination was needed. Idaho lost in an initial proceeding in a US district court, as a judge issued a temporary injunction against the abortion ban.

Persons: Roe, Wade, Biden, John Roberts, SCOTUS, Elizabeth Prelogar, Idaho’s, Amy Coney Barrett, ”, Roberts, Brett Kavanaugh, Barrett, “ improvidently, ” Barrett, Kavanaugh, ’, Elena Kagan, ‘, – Samuel Alito, Clarence Thomas, Neil Gorsuch, Alito, Thomas, Sonia Sotomayor, Kagan, Jackson, Sotomayor, Ketanji Brown Jackson, “, ” Alito, ” Jackson Organizations: CNN, Supreme, Republican, Democratic, Labor, Justice Department, Idaho, United, Jackson, Health Locations: Idaho, EMTALA . Idaho, SCOTUS Idaho, Sacramento, Dobbs v, Moyle v, United States

☆ How VC Stephen Hays scraped his life off rock bottom after addiction and a bipolar diagnosis to tackle mental health stigma
▼ + stars: | 2024-07-29 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +10 min

Some parents had voiced concerns about Hays' "background," he told Business Insider. In 2020, he started What If Ventures, a venture firm focused on investing in mental health startups. Hays's new public persona as a staunch mental health advocate also puts a certain pressure on him to perform his recovery — "and I hate that," he said. He wants to show people struggling with their own mental health that working to get well is good enough. Advertisement"I don't just want to destigmatize addiction and mental health issues — I want to destigmatize the journey of getting better," he said.

Persons: —, Stephen Hays, Hays, couldn't, didn't, They'd, it's, Christine, he'd, Amit Etkin, Etkin, he'll, that's, Stephen, Christopher Kim, Kim, Hays doesn't, It's Organizations: Service, Little League baseball, Business, Neuroscience, Ventures, West, Space Ventures, Atlantic City, Magazine, Deep Space Ventures, Alto Neuroscience, BI, Argosy Strategic Partners, Argosy Locations: Dallas, Texas, Atlantic, Las Vegas, Colorado, Wickenburg , Arizona

☆ Popular weight-loss and diabetes medications show promise for curbing smoking, study suggests
▼ + stars: | 2024-07-29 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +4 min

But experts emphasize that much more research is needed before using the medications off-label for smoking cessation. In a study published Monday in the journal Annals of Internal Medicine, researchers tracked the medical records of more than 200,000 people who started medications to treat type 2 diabetes, including nearly 6,000 people using semaglutide medications such as Ozempic. Over the course of a year, people who started using semaglutide were significantly less likely to have medical encounters for tobacco use disorders, prescriptions for medications for smoking cessation or counseling for smoking cessation than those who started other diabetes medications such as insulin and metformin. “A signal like this one cannot be ignored, particularly because of how consequential it could be if, in fact, we can have now a new medication for treating smoking cessation,” she said. But fewer than 1 in 10 adult cigarette smokers succeed in quitting each year, according to the new study, and options for smoking cessation treatment haven’t changed much in decades.

Persons: Disha, ”, Nora Volkow, ” Volkow, Dr, Sanjay Gupta, Volkow Organizations: CNN, Internal Medicine, Endeavor Health, National Institute on Drug, Get CNN, CNN Health, US Centers for Disease Control, American Cancer Society Locations: Chicago, United States

☆ Multi-agent systems are the next big thing in AI. Here's why VCs at NEA, Mayfield Fund, and Foundation Capital are excited.
▼ + stars: | 2024-07-29 | by ( Sri Muppidi | ) www.businessinsider.com time to read: +6 min

Startups are building AI agents that collaborate to fill out forms, dial customer service reps, and order food delivery. These "multi-agent systems" are the next hot thing, according to investors from NEA, Mayfield Fund, and Foundation Capital. Multi-agent systems are distributed systems of multiple specialized AI agents that work together toward a collective goal. AdvertisementIn contrast, multi-agent systems are built on top of LLMs and are designed to execute a task from start to finish. AdvertisementMayfield Fund's Navin Chaddha is optimistic — AI agents will serve as teammates to workers.

Persons: —, Spike Jonze's, that's, OpenAI's, NEA's Madison Faulkner, Devin, Warren Hui, Nitta, Satya Nitta, Ashpreet Bedi, Faulkner, Mayfield Fund's Navin Chaddha, …, It's Organizations: Service, NEA, Mayfield Fund, Foundation Capital, Business, Soul Ventures, Nvidia Locations: Italy, PitchBook, Japan

☆ Alzheimer’s blood test catches 90% of early dementia cases, study finds
▼ + stars: | 2024-07-28 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +10 min

CNN —A combined blood test for cognitive decline has a 90% accuracy rate in determining whether memory loss is due to Alzheimer’s disease, a new study found. “The p-tau217 blood test is turning out to be the most specific for Alzheimer’s and the one with the most validity. “These are absolutely transformational times.”How does a p-tau217 blood test work? The results of the blood tests were then measured against patient diagnoses provided by Swedish primary care doctors and specialists. “There’s no one more bullish on these tests than I am, but Alzheimer’s blood tests aren’t fully definitive yet,” he said.

Persons: CNN —, Sebastian Palmqvist, ” Palmqvist, ”, Maria Carrillo, Carrillo, “ You’re, that’s, ” Carrillo, “, ” Tau tangles, Richard Isaacson, Oskar Hansson, ” Hansson, Hansson, Isaacson, ” Isaacson Organizations: CNN, Lund University, “, Alzheimer’s Association, International Conference Locations: Sweden, Alzheimer’s, Florida, United States, Philadelphia

☆ She couldn’t stop thinking about the guy she met at the Athens Olympics. Then a message from him changed her life
▼ + stars: | 2024-07-26 | by ( Francesca Street | ) edition.cnn.com time to read: +26 min

So I thought, ‘Let me see if I can go to the Athens Olympics. An unexpected opportunityOmaira got to watch the final dress rehearsal of the opening ceremony of the Athens 2004 Olympic Games on August 13, 2004. And then Omaira was off to work at the shooting center, where the Games’ shooting events were held. But while Omaira was cultivating a pretty heady crush, Dimitris didn’t really have time to engage with his potential feelings. Omaira GillThis year marks 20 years since Omaira and Dimitris crossed paths at the Athens Olympics.

Persons: CNN — Omaira Gill, ” Omaira, ‘ I’m, ’, –, Omaira, ’ ”, … ’, “, ”, Omaira didn’t, “ I’d, David Gray MD, she’d, ’ Omaira Gill, Dimitris Athanasiou, Dimitris, ‘, they’re, ” Dimitris, ” Dimitris ’, hadn’t, Dimitris who’d, he’d, Dimtiris, Dimitris didn’t, Dimitris quizzed, “ Will, She’d, I’m, … ’ ”, couldn’t, didn’t, “ You’ve, Dimitris ’, that’s, we’d, Omaira Gill, Paulo Coelho, “ Omaira, ” Here's Dimitris, Omaira Gill Omaira, Hermes, Dimitiris, Hector, Orion, they’ll, “ Hermes, We’re, Dimitris – Organizations: CNN, Olympic, CNN Travel, Athens, “, ‘ Volunteers, Uni, Reuters, Olympics, Olympic Games, Paralympic, MSN, Omaira, ”, Athens Olympics, Stade de France, Disneyland Locations: Athens, Greece, Birmingham, United Kingdom, London, inbox, Omaira, Pakistan, India, Paris, Disneyland Paris, Europe

☆ How the AI revolution could cost you your job without replacing you
▼ + stars: | 2024-07-26 | by ( Jacob Zinkula | ) www.businessinsider.com time to read: +6 min

But as tech firms plan to invest billions of dollars in generative AI technologies, there's been another explanation for job cuts. While there's been a mountain of speculation about if and when AI technologies like ChatGPT could displace workers, their near-term impact on job losses could be less about job replacement and more about the cost of AI investments. The risks of AI job replacement remains to be seenIn the big picture, Netzer said he expects AI technologies to be an "enhancer rather than a replacer of jobs" in the years ahead. Advertisement"For many jobs, AI is likely to enhance our job, allowing us to spend more time on the things we enjoy doing and less time on the mundane," he said. AdvertisementBenedikt Frey pointed to translators as one profession that has seen fewer employment opportunities due to generative AI, per his research.

Persons: —, there's, Goldman Sachs, Mark Zuckerberg, Meta, Sundar Pichai, Daniel Rausch, Dan Ives, It's, Carl Benedikt Frey, Netzer, Benedikt Frey Organizations: Service, Apple, Microsoft, Industry, Business, Google, Amazon, Alexa, Fire, Wedbush Securities, Big Tech, FT, Columbia Business School, University of Oxford

☆ Rohan Bopanna’s path to the Olympics, via a Grand Slam and doubles world No 1
▼ + stars: | 2024-07-26 | by ( Matthew Futterman | ) www.nytimes.com time to read: +15 min

He needed to practice Iyengar yoga: a style that focuses on alignment. There, he came to know the father of Mahesh Bhupathi, one of India’s most successful players and a Grand Slam doubles champion. Polamarasetty told Bopanna that his knee wasn’t his problem. The kismet of Iyengar might have saved his knees, but none of the rest — the first Grand Slam title, the being doubles world No. Bopanna’s partner, Matwe Middelkoop, wanted to play with another Dutchman to better prepare for the Olympics and Davis Cup.

Persons: Rohan Bopanna’s, He’d, Matthew Ebden, Bopanna, Sriram Balaji, Fabien Reboul, Edouard Roger, Vasselin, Elsa, Getty, ” Bopanna, Rohan Bopanna, Bill Gates, Paul Allen, didn’t, Mohan Polamarasetty, Jaya, Polamarasetty, Iyengar, Mohan, “, ”, Bopanna’s, Clive Brunskill, Mahesh Bhupathi, Bhupathi, Boppanna, Haq Qureshi, Qureshi, Matthew Stockman, Prince Albert in, “ It’s, ” Polmarasetty, Max Purcell, Matwe Middelkoop, Ebden, Scott Davidoff, Supriya, Tridha, ” Davidoff, William West, Daniel Goldfarb, Shi Tang, Daniel Pockett Getty Organizations: All England Club, Olympics, Microsoft, University of Washington, Iyengar, Google, Jaya, Aisam, Getty, Pak Express, U.S ., Peace, Davis, Getty Images Locations: India, Coorg, Bangalore —, Bangalore, Pune, Chennai, Pakistan, South Asia, Prince Albert in Monaco, Australia, AFP

☆ Gaza: US physicians pen letter to Biden and Harris
▼ + stars: | 2024-07-26 | by ( Sahar Akbarzai | ) edition.cnn.com time to read: +8 min

Sources told CNN the president was expected to be as forceful as he has ever been in pushing Netanyahu to agree to a deal. Mohammed Salem/ReutersThe ‘only independent monitors’ in GazaDr. Adam Hamawy, a US plastic surgeon and former US Army combat trauma surgeon, told CNN on Thursday, “there’s no one getting firsthand accounts other than physicians. In signing the letter, Perlmutter told CNN that he hopes “the average American can feel the pain we feel on a daily basis. “Everyone in Gaza is sick, injured, or both,” with few exceptions, their letter said. We are simply physicians and nurses who cannot remain silent about what we saw in Gaza.” the letter said.

Persons: Joe Biden, Kamala Harris, ”, “, Feroze Sidwa, Biden, Benjamin Netanyahu, Netanyahu, Israel, Khan Younis, Mohammed Salem, Adam Hamawy, … we’re, you’re, who’ve, Hamawy, people’s, Tammy Duckworth, Mark Perlmutter, Perlmutter, hadn’t, ” Perlmutter, They’ll, Israel’s, Tala Alrajjal, Sam Fossum, Eugenia Ugrinovich Organizations: CNN, White, Humanitarian Law, European Hospital, Nasser Hospital, US Army, Gaza, Israel Defense Forces, World Surgical Association, Gazan Health Ministry, Health Organization, United Nations Locations: Gaza, Ukraine, Iraq, Israel, US, Sarajevo, New York City, Khan, Rafah, North Carolina

☆ Bristol Myers surges 10%, its biggest increase since 2008, after boosting profit forecast
▼ + stars: | 2024-07-26 | by ( Kelly Cloonan | ) www.businessinsider.com time to read: +3 min

Bristol Myers boosted its adjusted earnings for the year to between 60 and 90 cents a share, up 20 cents from its last forecast. AdvertisementOf Bristol Myers' existing drugs, Eliquis saw a 7% increase in sales year-over-year. Cancer drug Opdivo and blood cancer treatment Revlimid also saw promising results and beat quarterly sales estimates. The company reiterated its plan to cut $1.5 billion in costs by 2025, which was announced at its last quarterly earnings call. Bristol Myers is only the latest of a host of other drugmakers to raise their earnings guidance this week.

Persons: Myers, —, Bristol Myers, Christopher Boerner, Eliquis, Revlimid, David Elkins, Boerner, AbbVie Organizations: Bristol, Myers Squibb, Service, Cancer, FDA, AstraZeneca, Roche, Sanofi Locations: Bristol

☆ Why the Fed won't cut rates until December, according to Bank of America
▼ + stars: | 2024-07-26 | by ( Kelly Cloonan | ) www.businessinsider.com time to read: +1 min

The Federal Reserve will wait until December to cut interest rates, Bank of America economists say. The forecast runs counter to consensus, with 90% of investors expecting a first cut in September. download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . AdvertisementIn a Thursday research note, Bank of America reiterated its prediction for rate cuts to begin in December, even with a majority of investors expecting one in September. Meanwhile, 90% of investors expect a cut in September, according to the CME FedWatch tool.

Persons: BofA, — Organizations: Federal, Bank of America, Service, Business

☆ I decided not to have a second child and have no regrets. The benefits are just too good.
▼ + stars: | 2024-07-26 | by ( Nicole Findlay | ) www.businessinsider.com time to read: +4 min

The second time, I had a healthy pregnancy that resulted in a perfect baby boy, but for the first six months of that pregnancy, I struggled mentally. After a loss, the second pregnancy didn't seem real. Travel is easier and cheaperObviously, by choosing to have only one child, our expenses are lower, which allows us to travel more. The overall cost wasn't the reason why we didn't have a second child, but the extra money is definitely a benefit. I play moreA family member once told me, "An only child is a lonely child."

Persons: I'm, it's Organizations: Service, Business

☆ The USWNT kicks off in France as a team in transition – and one that’s looking to make a point
▼ + stars: | 2024-07-25 | by ( Kyle Feldscher | ) edition.cnn.com time to read: +9 min

“We want to make this environment comfortable, but also know, you know, what the standard is – you’re here for a reason,” said Lindsey Horan, the midfielder who serves as the team’s captain. And we want to get back to being the best in the world.”“So, we need those players. It was arguably Hayes’ first tough decision as the manager of the women’s team after coming on board in late 2023 following a successful decade-plus at Chelsea FC in London. Even still, she is finding it easier than anticipated to get her team to come together. I cannot finish the ball for players, but I can certainly coach to put players in positions.”

Persons: Emma Hayes, ”, Lindsey Horan, “, that’s, Sophia Smith, Trinity Rodman, Rose Lavelle, Alyssa Naeher, Hayes, Alex Morgan, Hayes ’, “ I’ve, Sam Coffey, Coffey, It’s, – Hayes, ” Hayes, It’ll, Mallory Swanson, who’s, Swanson, ” Swanson, it’s, Morgan, Smith, Rodman, Horan, –, Carli Lloyd, Abby Wambach, Mia Hamm, I’m Organizations: Paris CNN —, US, National Team, Costa, Paris Games, Zambia, Stade de Nice, Chelsea FC, US women’s, USA, American, flailing Locations: Washington , DC, Costa Rica, France, Tokyo, Australia, New Zealand, Nice, London, Zambia

☆ GE HealthCare taps Amazon Web Services to build generative AI for medical use
▼ + stars: | 2024-07-25 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +3 min

GE HealthCare on Thursday announced it is teaming up with Amazon Web Services to build new generative artificial intelligence models and tools that can efficiently analyze complex medical data. GE HealthCare, which offers medical imaging, ultrasound, patient care and pharmaceutical diagnostic solutions, believes generative AI can help. GE HealthCare offers its own AI tools, but its partnership with AWS will supply the company with the technical infrastructure required to quickly build generative AI models and tools at scale. GE HealthCare will use AWS' solutions like Amazon Bedrock and Amazon SageMaker, according to a release Thursday. Kass-Hout said GE HealthCare maintains rigorous testing and standards before bringing products to market, and the same will be true with the generative AI applications it develops.

Persons: Dr, Taha Kass, Kass, Hout, Matt Wood Organizations: GE, Amazon Web Services, Deloitte, GE HealthCare, AWS, CNBC

☆ Russia's war-driven economic growth is a mirage, and more sanctions are needed to keep pressure on, European finance ministers say
▼ + stars: | 2024-07-24 | by ( Filip De Mott | ) www.businessinsider.com time to read: +3 min

download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Sanctions are instead straining Russia, and could do more if the West is patient enough, a group of eight European finance ministers jointly argued in The Guardian. Large financial stimulus is the chief tailwind keeping Russia resistant, but the ministers noted that isn't an endless pillar of support. The eight ministers argued that these conditions make Western sanctions more important than ever, adding that pressure should be cranked up on Russia. They noted that if the West is patient enough, Russia's confidence will eventually slump as long-term damage takes hold.

Persons: — Organizations: Service, Guardian, Business, Kremlin Locations: Moscow, Russia, Ukraine, Sweden, Poland, Netherlands, Soviet Union, Belarus, Asia

Search resuls for: "Patient"

25 mentions found